Biotech Investors & VC Firms in United States
1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.
Ride Home
LynnwoodPre-Seed–Seed$100K – $5M
1 person
Asclepius Life Sciences Fund, LP
New YorkSeed–Series B
4 people
Proton Enterprises
New YorkSeed–Series A
4 people
SRI Ventures
Silicon ValleySeed–Series A
4 people
Abbhi Capital
MiamiPre-Seed–Late Stage
Curie.Bio
CambridgeSeed–Series A$7M
9 people
Lunsford Capital
LouisvilleSeed–Series A
3 people
Zynext Ventures
PenningtonPre-Seed–Series B
3 people
Dynamk Capital
New YorkSeed–Series B
4 people
Emergent Technologies, Inc.
AustinSeed–Series A
3 people
OphthaFund
CharlestonPre-Seed–Series A
Gilmartin Capital LLC
LarkspurSeries A–Late Stage
2 people
Sustainable Conversion Ventures
Sun LakesSeed–Late Stage
2 people
Blue Ledge Capital
Seed–Growth
1 person
Colt Ventures
DallasSeed–Growth$15M
3 people
Crede CapitalGroup
Los Angeles$5M – $50M
Harvard Business School Alumni Angels of Greater New York
New YorkPre-Seed–Seed
3 people
ROC Venture Group
NaplesSeed–Series A
Cambridge Capital Group
CambridgePre-Seed–Growth
2 people
Yu Galaxy
Silicon ValleyPre-Seed–Seed
2 people
Global Health Investment Fund
New York
1 person
Northwell Holdings
New YorkSeed–Late Stage
1 person
Qiming Venture Partners USA
CambridgeSeed–Series A
1 person
eGenesis, Inc. Full-time
New York
3 people
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.















































